| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Germ Cells | 7 | 2023 | 634 | 2.670 |
Why?
|
| Induced Pluripotent Stem Cells | 8 | 2023 | 1851 | 1.510 |
Why?
|
| Estrogens | 10 | 2021 | 1521 | 1.470 |
Why?
|
| Embryoid Bodies | 4 | 2021 | 65 | 1.390 |
Why?
|
| Endocrine Disruptors | 8 | 2021 | 264 | 1.310 |
Why?
|
| Epigenesis, Genetic | 10 | 2021 | 3794 | 0.980 |
Why?
|
| DNA Methylation | 14 | 2021 | 4392 | 0.960 |
Why?
|
| Germ Layers | 2 | 2022 | 72 | 0.920 |
Why?
|
| Sex Determination Processes | 3 | 2021 | 60 | 0.910 |
Why?
|
| Chick Embryo | 10 | 2021 | 982 | 0.890 |
Why?
|
| Phenols | 7 | 2018 | 516 | 0.880 |
Why?
|
| Trans-Activators | 22 | 2010 | 2851 | 0.850 |
Why?
|
| Feminization | 2 | 2021 | 19 | 0.840 |
Why?
|
| Estradiol | 9 | 2013 | 1937 | 0.840 |
Why?
|
| Promoter Regions, Genetic | 17 | 2018 | 5780 | 0.830 |
Why?
|
| Chickens | 3 | 2021 | 858 | 0.800 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2021 | 3606 | 0.740 |
Why?
|
| Gastrula | 1 | 2021 | 82 | 0.730 |
Why?
|
| Benzhydryl Compounds | 7 | 2018 | 915 | 0.710 |
Why?
|
| Testis | 3 | 2022 | 792 | 0.690 |
Why?
|
| Nuclear Proteins | 23 | 2011 | 5789 | 0.690 |
Why?
|
| Genomic Imprinting | 5 | 2017 | 329 | 0.670 |
Why?
|
| Neoplastic Cells, Circulating | 8 | 2018 | 943 | 0.630 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2023 | 491 | 0.620 |
Why?
|
| Folic Acid Deficiency | 1 | 2019 | 117 | 0.610 |
Why?
|
| Fluorocarbons | 1 | 2023 | 492 | 0.610 |
Why?
|
| Sulfites | 1 | 2018 | 83 | 0.590 |
Why?
|
| Body Patterning | 2 | 2019 | 632 | 0.590 |
Why?
|
| Cell Culture Techniques | 4 | 2021 | 1662 | 0.590 |
Why?
|
| Testicular Neoplasms | 1 | 2023 | 800 | 0.570 |
Why?
|
| Lentivirus | 3 | 2011 | 507 | 0.560 |
Why?
|
| Estrogen Receptor Modulators | 2 | 2009 | 58 | 0.560 |
Why?
|
| Phosphotransferases | 1 | 2018 | 303 | 0.550 |
Why?
|
| Apoptosis Regulatory Proteins | 18 | 2010 | 1135 | 0.540 |
Why?
|
| Prenatal Exposure Delayed Effects | 7 | 2023 | 2518 | 0.520 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1864 | 0.510 |
Why?
|
| Mammary Glands, Animal | 5 | 2014 | 272 | 0.510 |
Why?
|
| Pluripotent Stem Cells | 3 | 2017 | 796 | 0.470 |
Why?
|
| Estrogen Receptor alpha | 5 | 2014 | 583 | 0.470 |
Why?
|
| Gene Expression Profiling | 18 | 2019 | 9417 | 0.460 |
Why?
|
| Transcription Factors | 16 | 2023 | 12116 | 0.450 |
Why?
|
| HIV-1 | 19 | 2007 | 6858 | 0.450 |
Why?
|
| Polymorphism, Genetic | 5 | 2013 | 4242 | 0.450 |
Why?
|
| Transcriptional Activation | 11 | 2018 | 1754 | 0.440 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2013 | 1320 | 0.440 |
Why?
|
| Virus Cultivation | 3 | 2011 | 88 | 0.420 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2017 | 8542 | 0.420 |
Why?
|
| RNA, Messenger | 25 | 2014 | 12759 | 0.420 |
Why?
|
| Estrogen Antagonists | 1 | 2013 | 150 | 0.410 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 865 | 0.410 |
Why?
|
| Epigenomics | 2 | 2018 | 942 | 0.410 |
Why?
|
| Fetal Blood | 1 | 2019 | 1347 | 0.400 |
Why?
|
| Avian Proteins | 1 | 2012 | 79 | 0.400 |
Why?
|
| Sequence Analysis, DNA | 5 | 2018 | 4739 | 0.400 |
Why?
|
| Aromatase | 1 | 2012 | 147 | 0.390 |
Why?
|
| Cell Differentiation | 15 | 2023 | 11512 | 0.370 |
Why?
|
| Respirovirus | 11 | 2000 | 31 | 0.370 |
Why?
|
| Gene Expression Regulation | 15 | 2019 | 11874 | 0.370 |
Why?
|
| Animals | 95 | 2023 | 168202 | 0.370 |
Why?
|
| Virology | 1 | 2011 | 75 | 0.360 |
Why?
|
| Sex Determination Analysis | 1 | 2010 | 46 | 0.360 |
Why?
|
| Drug Resistance, Neoplasm | 10 | 2018 | 5304 | 0.360 |
Why?
|
| src-Family Kinases | 1 | 2013 | 535 | 0.350 |
Why?
|
| Trialkyltin Compounds | 3 | 2018 | 6 | 0.350 |
Why?
|
| Sex Chromosomes | 1 | 2010 | 101 | 0.340 |
Why?
|
| Retinoid X Receptors | 3 | 2019 | 91 | 0.340 |
Why?
|
| Base Sequence | 30 | 2007 | 12420 | 0.340 |
Why?
|
| Immunohistochemistry | 6 | 2021 | 11069 | 0.320 |
Why?
|
| Virus Assembly | 2 | 2009 | 139 | 0.320 |
Why?
|
| Membrane Proteins | 7 | 2016 | 7847 | 0.320 |
Why?
|
| Adipogenesis | 4 | 2023 | 366 | 0.310 |
Why?
|
| Apoptosis | 7 | 2014 | 9476 | 0.310 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2019 | 223 | 0.310 |
Why?
|
| Chemokines, CXC | 7 | 2003 | 416 | 0.310 |
Why?
|
| Mesoderm | 4 | 2018 | 674 | 0.310 |
Why?
|
| Genome | 1 | 2016 | 1737 | 0.300 |
Why?
|
| Receptors, Progesterone | 4 | 2016 | 1129 | 0.300 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2014 | 3776 | 0.300 |
Why?
|
| Mice | 57 | 2023 | 81368 | 0.290 |
Why?
|
| Untranslated Regions | 1 | 2007 | 29 | 0.290 |
Why?
|
| CpG Islands | 3 | 2018 | 1192 | 0.290 |
Why?
|
| Single-Cell Analysis | 7 | 2022 | 2447 | 0.280 |
Why?
|
| Codon, Initiator | 1 | 2007 | 50 | 0.280 |
Why?
|
| Sex Differentiation | 2 | 2021 | 73 | 0.280 |
Why?
|
| Breast Neoplasms | 18 | 2018 | 20988 | 0.280 |
Why?
|
| Gene Expression | 10 | 2017 | 7569 | 0.280 |
Why?
|
| Cells, Cultured | 14 | 2022 | 18937 | 0.280 |
Why?
|
| Cell Movement | 3 | 2017 | 5201 | 0.270 |
Why?
|
| Trinucleotide Repeat Expansion | 3 | 2014 | 247 | 0.270 |
Why?
|
| Interleukin-7 | 1 | 2007 | 143 | 0.270 |
Why?
|
| Molecular Sequence Data | 24 | 2007 | 17630 | 0.260 |
Why?
|
| Benzo(a)pyrene | 2 | 2023 | 27 | 0.260 |
Why?
|
| Melanoma, Experimental | 3 | 2001 | 561 | 0.260 |
Why?
|
| COS Cells | 6 | 2011 | 1130 | 0.260 |
Why?
|
| Transcription, Genetic | 23 | 2016 | 7583 | 0.250 |
Why?
|
| Embryo, Mammalian | 4 | 2022 | 1670 | 0.250 |
Why?
|
| DNA-Binding Proteins | 9 | 2017 | 9586 | 0.250 |
Why?
|
| Huntington Disease | 4 | 2014 | 1144 | 0.250 |
Why?
|
| Obesity | 7 | 2023 | 12934 | 0.250 |
Why?
|
| Chemokine CXCL12 | 8 | 2017 | 454 | 0.250 |
Why?
|
| Transfection | 11 | 2016 | 5765 | 0.250 |
Why?
|
| Receptors, CCR5 | 1 | 2007 | 486 | 0.250 |
Why?
|
| Embryonic Stem Cells | 4 | 2018 | 1262 | 0.250 |
Why?
|
| Keratins | 3 | 2022 | 498 | 0.250 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2023 | 1642 | 0.240 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2018 | 254 | 0.230 |
Why?
|
| Toxicogenetics | 1 | 2004 | 20 | 0.230 |
Why?
|
| Cell Line | 29 | 2013 | 15577 | 0.230 |
Why?
|
| Polymerase Chain Reaction | 11 | 2018 | 6074 | 0.220 |
Why?
|
| Epithelial Cells | 3 | 2017 | 3672 | 0.220 |
Why?
|
| Genes, Reporter | 4 | 2007 | 1525 | 0.220 |
Why?
|
| Acquired Immunodeficiency Syndrome | 6 | 2007 | 2197 | 0.220 |
Why?
|
| Cell Line, Tumor | 18 | 2019 | 16968 | 0.220 |
Why?
|
| HIV Envelope Protein gp120 | 4 | 1997 | 914 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 14 | 2014 | 6126 | 0.210 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2019 | 682 | 0.210 |
Why?
|
| Gametogenesis | 1 | 2023 | 26 | 0.210 |
Why?
|
| Genes, Viral | 8 | 1999 | 649 | 0.210 |
Why?
|
| Reference Standards | 1 | 2006 | 1003 | 0.210 |
Why?
|
| Giant Cells | 4 | 2000 | 188 | 0.210 |
Why?
|
| Humans | 102 | 2023 | 760740 | 0.200 |
Why?
|
| Cloning, Molecular | 15 | 2002 | 4172 | 0.200 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 3 | 2011 | 135 | 0.200 |
Why?
|
| Inheritance Patterns | 2 | 2021 | 341 | 0.200 |
Why?
|
| Chemokine CCL5 | 2 | 2000 | 214 | 0.200 |
Why?
|
| Gonads | 1 | 2022 | 109 | 0.190 |
Why?
|
| Repressor Proteins | 4 | 2017 | 2985 | 0.190 |
Why?
|
| Dipeptidyl Peptidase 4 | 2 | 1998 | 91 | 0.190 |
Why?
|
| Pregnancy, Animal | 1 | 2022 | 124 | 0.190 |
Why?
|
| Ovary | 4 | 2023 | 959 | 0.190 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2018 | 1520 | 0.190 |
Why?
|
| Amino Acid Sequence | 24 | 2002 | 13442 | 0.190 |
Why?
|
| Introns | 4 | 2013 | 968 | 0.180 |
Why?
|
| Protein Biosynthesis | 5 | 2007 | 2100 | 0.180 |
Why?
|
| Adipocytes | 2 | 2018 | 1187 | 0.180 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2002 | 2747 | 0.180 |
Why?
|
| Melanocytes | 3 | 2001 | 509 | 0.180 |
Why?
|
| MicroRNAs | 5 | 2023 | 3802 | 0.180 |
Why?
|
| Reassortant Viruses | 1 | 2000 | 36 | 0.180 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 1745 | 0.180 |
Why?
|
| Calcium-Binding Proteins | 4 | 2016 | 1066 | 0.180 |
Why?
|
| Virus Replication | 13 | 2009 | 2427 | 0.180 |
Why?
|
| Receptors, Androgen | 2 | 2018 | 1079 | 0.180 |
Why?
|
| Baculoviridae | 1 | 2000 | 115 | 0.180 |
Why?
|
| Oryzias | 1 | 2000 | 20 | 0.180 |
Why?
|
| RNA, Neoplasm | 3 | 2006 | 749 | 0.180 |
Why?
|
| beta-Galactosidase | 2 | 2000 | 574 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2016 | 1650 | 0.170 |
Why?
|
| Parainfluenza Virus 1, Human | 4 | 1995 | 25 | 0.170 |
Why?
|
| Mammals | 2 | 2023 | 1131 | 0.170 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2000 | 52 | 0.170 |
Why?
|
| Chromatin | 4 | 2021 | 2955 | 0.170 |
Why?
|
| Female | 48 | 2023 | 392203 | 0.170 |
Why?
|
| Tamoxifen | 4 | 2013 | 965 | 0.170 |
Why?
|
| Viral Proteins | 7 | 2001 | 1799 | 0.170 |
Why?
|
| X Chromosome | 3 | 2004 | 816 | 0.170 |
Why?
|
| Mitosis | 3 | 2019 | 1187 | 0.160 |
Why?
|
| Interleukin-4 | 2 | 2000 | 1146 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2018 | 5672 | 0.160 |
Why?
|
| Smad4 Protein | 5 | 2006 | 191 | 0.160 |
Why?
|
| Plasmids | 6 | 2001 | 2265 | 0.160 |
Why?
|
| RNA, Viral | 9 | 2001 | 2838 | 0.160 |
Why?
|
| Receptors, CXCR4 | 3 | 2017 | 727 | 0.160 |
Why?
|
| 5-Methylcytosine | 2 | 2016 | 147 | 0.160 |
Why?
|
| Transcription Factor AP-2 | 2 | 2017 | 78 | 0.160 |
Why?
|
| DNA Primers | 10 | 2007 | 2817 | 0.150 |
Why?
|
| Stromal Cells | 3 | 2019 | 1329 | 0.150 |
Why?
|
| Adipose Tissue, White | 2 | 2018 | 359 | 0.150 |
Why?
|
| Male | 34 | 2023 | 360402 | 0.150 |
Why?
|
| SOXF Transcription Factors | 1 | 2017 | 31 | 0.150 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 224 | 0.150 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2000 | 397 | 0.150 |
Why?
|
| Gene Products, env | 2 | 1998 | 250 | 0.150 |
Why?
|
| Pregnancy | 12 | 2023 | 29869 | 0.150 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2015 | 2916 | 0.150 |
Why?
|
| Body Weight | 2 | 2018 | 4615 | 0.140 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2017 | 332 | 0.140 |
Why?
|
| Cell Aggregation | 1 | 2017 | 239 | 0.140 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2017 | 92 | 0.140 |
Why?
|
| Luminescent Proteins | 1 | 2000 | 836 | 0.140 |
Why?
|
| Luciferases | 4 | 2007 | 712 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2019 | 3634 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 4 | 2014 | 4408 | 0.140 |
Why?
|
| Prolactin | 1 | 2019 | 625 | 0.140 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 262 | 0.140 |
Why?
|
| Cell Separation | 3 | 2017 | 1718 | 0.140 |
Why?
|
| Cyclopropanes | 1 | 2018 | 432 | 0.140 |
Why?
|
| Cytosine | 1 | 2018 | 211 | 0.140 |
Why?
|
| Mitochondrial Proteins | 3 | 2009 | 974 | 0.140 |
Why?
|
| Genes, Homeobox | 1 | 2017 | 286 | 0.130 |
Why?
|
| Genetic Vectors | 4 | 2000 | 3392 | 0.130 |
Why?
|
| Neoplasm Metastasis | 3 | 2014 | 4910 | 0.130 |
Why?
|
| Chromosome Mapping | 2 | 2009 | 4611 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 7 | 2018 | 2013 | 0.130 |
Why?
|
| Gene Frequency | 4 | 2014 | 3601 | 0.130 |
Why?
|
| Placenta | 2 | 2022 | 1709 | 0.130 |
Why?
|
| Genome-Wide Association Study | 3 | 2018 | 12661 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 2 | 2021 | 1350 | 0.130 |
Why?
|
| Genomic Instability | 2 | 2018 | 709 | 0.130 |
Why?
|
| Sequence Homology, Nucleic Acid | 8 | 2002 | 1058 | 0.130 |
Why?
|
| Parainfluenza Virus 3, Human | 4 | 1988 | 25 | 0.130 |
Why?
|
| Cardiac Tamponade | 1 | 1997 | 173 | 0.130 |
Why?
|
| Cell Cycle | 3 | 2015 | 2929 | 0.130 |
Why?
|
| Blotting, Western | 8 | 2014 | 5034 | 0.130 |
Why?
|
| Prostate | 4 | 2017 | 1773 | 0.130 |
Why?
|
| Environmental Exposure | 4 | 2021 | 4483 | 0.130 |
Why?
|
| Ethinyl Estradiol | 2 | 2013 | 113 | 0.120 |
Why?
|
| Reproduction | 1 | 2000 | 646 | 0.120 |
Why?
|
| Fibrosarcoma | 1 | 1997 | 308 | 0.120 |
Why?
|
| Receptors, Estrogen | 4 | 2017 | 2208 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.120 |
Why?
|
| bcl-X Protein | 2 | 2015 | 410 | 0.120 |
Why?
|
| Iodide Peroxidase | 1 | 2016 | 294 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2018 | 575 | 0.120 |
Why?
|
| DNA, Complementary | 6 | 2002 | 1989 | 0.120 |
Why?
|
| Microarray Analysis | 3 | 2013 | 748 | 0.120 |
Why?
|
| Xenopus laevis | 1 | 2018 | 963 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2013 | 10754 | 0.120 |
Why?
|
| Japan | 3 | 2007 | 1372 | 0.120 |
Why?
|
| Protein Kinase C | 2 | 1998 | 1202 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2007 | 3730 | 0.110 |
Why?
|
| Phenylthiohydantoin | 1 | 2015 | 205 | 0.110 |
Why?
|
| RNA Interference | 5 | 2014 | 2829 | 0.110 |
Why?
|
| Genetic Variation | 5 | 1997 | 6561 | 0.110 |
Why?
|
| Prostatic Neoplasms | 5 | 2021 | 11107 | 0.110 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 2 | 2010 | 56 | 0.110 |
Why?
|
| Chemokines | 1 | 2017 | 954 | 0.110 |
Why?
|
| Heart Neoplasms | 1 | 1997 | 362 | 0.110 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2007 | 767 | 0.110 |
Why?
|
| Carrier Proteins | 5 | 2014 | 4937 | 0.110 |
Why?
|
| E1A-Associated p300 Protein | 3 | 2002 | 123 | 0.110 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1994 | 436 | 0.110 |
Why?
|
| Wnt Proteins | 2 | 2015 | 718 | 0.110 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 344 | 0.110 |
Why?
|
| PPAR gamma | 3 | 2023 | 484 | 0.100 |
Why?
|
| Antineoplastic Agents | 6 | 2015 | 13635 | 0.100 |
Why?
|
| Immediate-Early Proteins | 1 | 2015 | 444 | 0.100 |
Why?
|
| RNA | 2 | 2021 | 2713 | 0.100 |
Why?
|
| Transforming Growth Factor alpha | 2 | 2003 | 135 | 0.100 |
Why?
|
| Epithelium | 3 | 2013 | 1603 | 0.100 |
Why?
|
| Microcirculation | 1 | 1997 | 1272 | 0.100 |
Why?
|
| Gestational Age | 2 | 2019 | 3577 | 0.100 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2013 | 268 | 0.100 |
Why?
|
| HIV Infections | 4 | 2000 | 17342 | 0.100 |
Why?
|
| Trinucleotide Repeats | 1 | 2013 | 257 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2019 | 1403 | 0.100 |
Why?
|
| DNA | 9 | 2010 | 7196 | 0.100 |
Why?
|
| Kidney | 6 | 2007 | 7044 | 0.100 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 1998 | 817 | 0.100 |
Why?
|
| Embryonic and Fetal Development | 2 | 2004 | 420 | 0.090 |
Why?
|
| Disorders of Sex Development | 1 | 2012 | 128 | 0.090 |
Why?
|
| Retinoblastoma Protein | 1 | 2015 | 671 | 0.090 |
Why?
|
| Blotting, Northern | 4 | 2002 | 1545 | 0.090 |
Why?
|
| Sex Characteristics | 2 | 2021 | 2637 | 0.090 |
Why?
|
| Genes | 5 | 2002 | 1823 | 0.090 |
Why?
|
| Aniline Compounds | 2 | 2015 | 1068 | 0.090 |
Why?
|
| Cell Lineage | 3 | 2022 | 2553 | 0.090 |
Why?
|
| Protein Binding | 8 | 2017 | 9345 | 0.090 |
Why?
|
| Computational Biology | 2 | 2022 | 3509 | 0.090 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2010 | 25 | 0.090 |
Why?
|
| Mice, Inbred NOD | 4 | 2016 | 1827 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 11 | 2023 | 22117 | 0.090 |
Why?
|
| Membrane Glycoproteins | 3 | 2016 | 3688 | 0.090 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2011 | 257 | 0.090 |
Why?
|
| T-Lymphocytes | 6 | 1998 | 10175 | 0.090 |
Why?
|
| RNA, Small Interfering | 5 | 2015 | 3419 | 0.090 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2015 | 423 | 0.090 |
Why?
|
| Signal Transduction | 11 | 2019 | 23415 | 0.090 |
Why?
|
| Neostriatum | 1 | 2011 | 247 | 0.090 |
Why?
|
| YY1 Transcription Factor | 1 | 2010 | 60 | 0.090 |
Why?
|
| Neoplastic Processes | 1 | 2009 | 35 | 0.090 |
Why?
|
| Benzimidazoles | 2 | 2012 | 858 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2010 | 147 | 0.080 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2011 | 324 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 1999 | 4365 | 0.080 |
Why?
|
| Neuraminidase | 3 | 1998 | 195 | 0.080 |
Why?
|
| Point Mutation | 1 | 1994 | 1595 | 0.080 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 2413 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2019 | 2803 | 0.080 |
Why?
|
| Weight Gain | 2 | 2018 | 2349 | 0.080 |
Why?
|
| Fetus | 2 | 2013 | 1862 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1998 | 1836 | 0.080 |
Why?
|
| Sirtuin 1 | 1 | 2010 | 246 | 0.080 |
Why?
|
| Unfolded Protein Response | 1 | 2011 | 234 | 0.080 |
Why?
|
| Mutation | 9 | 2017 | 30015 | 0.080 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2015 | 799 | 0.080 |
Why?
|
| Viral Envelope Proteins | 3 | 1998 | 640 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 1890 | 0.080 |
Why?
|
| Ascorbic Acid | 1 | 2012 | 655 | 0.080 |
Why?
|
| Viral Fusion Proteins | 3 | 1999 | 100 | 0.080 |
Why?
|
| Alleles | 4 | 2013 | 6861 | 0.080 |
Why?
|
| Cell Survival | 4 | 2016 | 5780 | 0.080 |
Why?
|
| Disease Progression | 7 | 2015 | 13495 | 0.080 |
Why?
|
| Phylogeny | 4 | 2007 | 2805 | 0.080 |
Why?
|
| Choline Dehydrogenase | 1 | 2007 | 4 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2011 | 2467 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 502 | 0.080 |
Why?
|
| Melanoma | 3 | 2008 | 5696 | 0.080 |
Why?
|
| Haplotypes | 2 | 2007 | 2713 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2018 | 3088 | 0.070 |
Why?
|
| DNA, Viral | 7 | 1998 | 2194 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2017 | 1608 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2008 | 205 | 0.070 |
Why?
|
| Methylation | 2 | 2021 | 1077 | 0.070 |
Why?
|
| Cerebellum | 2 | 2013 | 1501 | 0.070 |
Why?
|
| Clone Cells | 2 | 2009 | 1657 | 0.070 |
Why?
|
| Sequence Alignment | 3 | 2002 | 2178 | 0.070 |
Why?
|
| Databases, Genetic | 1 | 2014 | 1742 | 0.070 |
Why?
|
| Decidua | 1 | 2007 | 82 | 0.070 |
Why?
|
| Blastocyst | 2 | 2022 | 432 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 3842 | 0.070 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2010 | 563 | 0.070 |
Why?
|
| Leupeptins | 1 | 2006 | 113 | 0.070 |
Why?
|
| Retinal Dehydrogenase | 2 | 2018 | 78 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 1718 | 0.070 |
Why?
|
| Mice, Nude | 4 | 2016 | 3606 | 0.070 |
Why?
|
| Receptors, Vasopressin | 1 | 2007 | 105 | 0.070 |
Why?
|
| Androgen Antagonists | 1 | 2015 | 1409 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2014 | 10429 | 0.070 |
Why?
|
| Sulfonamides | 2 | 2015 | 1977 | 0.070 |
Why?
|
| Receptors, Interleukin | 1 | 2007 | 243 | 0.070 |
Why?
|
| Cytokines | 2 | 1998 | 7373 | 0.070 |
Why?
|
| Phenotype | 4 | 2021 | 16572 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2016 | 3394 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2012 | 2601 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2023 | 22153 | 0.060 |
Why?
|
| Binding Sites | 3 | 2000 | 6051 | 0.060 |
Why?
|
| Exons | 3 | 2002 | 2381 | 0.060 |
Why?
|
| Up-Regulation | 4 | 2019 | 4117 | 0.060 |
Why?
|
| Morphogenesis | 2 | 2007 | 741 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 2527 | 0.060 |
Why?
|
| Mice, SCID | 3 | 2016 | 2625 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2015 | 3599 | 0.060 |
Why?
|
| Paclitaxel | 1 | 2013 | 1730 | 0.060 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2006 | 150 | 0.060 |
Why?
|
| Caenorhabditis elegans | 2 | 2011 | 1452 | 0.060 |
Why?
|
| Gamma Rays | 1 | 2006 | 318 | 0.060 |
Why?
|
| Breast | 2 | 2012 | 1963 | 0.060 |
Why?
|
| Muscle, Skeletal | 2 | 2018 | 4947 | 0.060 |
Why?
|
| Endometrial Neoplasms | 1 | 2014 | 1365 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2011 | 871 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 1745 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2006 | 451 | 0.060 |
Why?
|
| Genotype | 4 | 2007 | 12977 | 0.060 |
Why?
|
| Multigene Family | 3 | 2010 | 1076 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2007 | 1490 | 0.060 |
Why?
|
| Endometrium | 1 | 2007 | 403 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2010 | 2916 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 988 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 5 | 2007 | 3793 | 0.060 |
Why?
|
| Sexual Maturation | 1 | 2006 | 261 | 0.060 |
Why?
|
| Cholesterol | 2 | 2010 | 2902 | 0.060 |
Why?
|
| Histones | 3 | 2021 | 2577 | 0.060 |
Why?
|
| Macrophages | 3 | 2022 | 5758 | 0.060 |
Why?
|
| Fasting | 1 | 2010 | 1603 | 0.060 |
Why?
|
| Organogenesis | 1 | 2005 | 214 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2010 | 1503 | 0.060 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 1810 | 0.050 |
Why?
|
| Lymphatic Vessels | 1 | 2007 | 356 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2013 | 1277 | 0.050 |
Why?
|
| Cisplatin | 1 | 2009 | 1650 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18220 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 5319 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2812 | 0.050 |
Why?
|
| Gene Products, tat | 2 | 1993 | 111 | 0.050 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 13383 | 0.050 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 1994 | 0.050 |
Why?
|
| Oogenesis | 1 | 2023 | 124 | 0.050 |
Why?
|
| Ectoderm | 1 | 2022 | 137 | 0.050 |
Why?
|
| Cell Division | 2 | 2003 | 4457 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2008 | 1141 | 0.050 |
Why?
|
| Kinetics | 2 | 2004 | 6370 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2007 | 720 | 0.050 |
Why?
|
| Trophoblasts | 1 | 2004 | 224 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 2006 | 1085 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 20077 | 0.050 |
Why?
|
| Respirovirus Infections | 2 | 1999 | 51 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 4745 | 0.050 |
Why?
|
| Lysosomes | 1 | 2007 | 925 | 0.050 |
Why?
|
| Virion | 2 | 2001 | 422 | 0.050 |
Why?
|
| Parathyroid Hormone | 1 | 2008 | 1803 | 0.050 |
Why?
|
| Homozygote | 1 | 2006 | 1776 | 0.050 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 6345 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2014 | 717 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2001 | 76 | 0.050 |
Why?
|
| Chemotaxis | 3 | 1998 | 598 | 0.050 |
Why?
|
| Indicator Dilution Techniques | 1 | 2000 | 43 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 1998 | 3591 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2011 | 2063 | 0.040 |
Why?
|
| Spodoptera | 1 | 2000 | 141 | 0.040 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2000 | 49 | 0.040 |
Why?
|
| Miosis | 1 | 2019 | 9 | 0.040 |
Why?
|
| HLA-B35 Antigen | 1 | 1999 | 7 | 0.040 |
Why?
|
| Neuroblastoma | 1 | 2008 | 1248 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2009 | 2010 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 2 | 2011 | 420 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2006 | 2224 | 0.040 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2000 | 83 | 0.040 |
Why?
|
| Genome, Viral | 2 | 2001 | 665 | 0.040 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2000 | 158 | 0.040 |
Why?
|
| Mitochondria | 2 | 2017 | 3619 | 0.040 |
Why?
|
| Melanins | 1 | 2001 | 289 | 0.040 |
Why?
|
| Ovum | 1 | 2000 | 187 | 0.040 |
Why?
|
| Fibroblasts | 3 | 2019 | 4140 | 0.040 |
Why?
|
| Aldehyde Oxidase | 1 | 2018 | 4 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2019 | 67 | 0.040 |
Why?
|
| Peptides | 1 | 2011 | 4354 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2009 | 5863 | 0.040 |
Why?
|
| U937 Cells | 1 | 1999 | 261 | 0.040 |
Why?
|
| Lymphoma | 1 | 2008 | 1899 | 0.040 |
Why?
|
| Ligands | 2 | 2003 | 3268 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2019 | 26183 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 2425 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 1900 | 0.040 |
Why?
|
| Weaning | 1 | 2018 | 103 | 0.040 |
Why?
|
| Measles virus | 1 | 1998 | 67 | 0.040 |
Why?
|
| Gastrulation | 1 | 2018 | 36 | 0.040 |
Why?
|
| Staining and Labeling | 2 | 2017 | 1081 | 0.040 |
Why?
|
| TATA Box | 1 | 1998 | 127 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2008 | 2057 | 0.040 |
Why?
|
| MyoD Protein | 1 | 2018 | 142 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2022 | 1540 | 0.040 |
Why?
|
| Heterosexuality | 1 | 2000 | 309 | 0.040 |
Why?
|
| Viral Matrix Proteins | 2 | 1990 | 196 | 0.040 |
Why?
|
| Chemotactic Factors | 1 | 1998 | 197 | 0.040 |
Why?
|
| Allantois | 1 | 1997 | 33 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 17878 | 0.040 |
Why?
|
| Time Factors | 7 | 2022 | 39908 | 0.040 |
Why?
|
| Succinimides | 1 | 2017 | 81 | 0.040 |
Why?
|
| Mutagenesis | 4 | 2006 | 1230 | 0.040 |
Why?
|
| Benzamides | 2 | 2015 | 1371 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1999 | 433 | 0.040 |
Why?
|
| Chorion | 1 | 1997 | 114 | 0.040 |
Why?
|
| Genes, fos | 1 | 1997 | 175 | 0.040 |
Why?
|
| Fluoresceins | 1 | 2017 | 235 | 0.040 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1997 | 132 | 0.030 |
Why?
|
| Mice, Inbred ICR | 3 | 2007 | 364 | 0.030 |
Why?
|
| Reference Values | 2 | 2006 | 4919 | 0.030 |
Why?
|
| Models, Genetic | 2 | 2013 | 3431 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2017 | 164 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2019 | 321 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 1997 | 241 | 0.030 |
Why?
|
| E2F Transcription Factors | 1 | 2017 | 269 | 0.030 |
Why?
|
| Hemophilia A | 1 | 2000 | 359 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 5369 | 0.030 |
Why?
|
| Chromosomal Instability | 1 | 2017 | 178 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 596 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 4569 | 0.030 |
Why?
|
| Abdominal Neoplasms | 1 | 2018 | 287 | 0.030 |
Why?
|
| Membrane Fusion | 1 | 1998 | 266 | 0.030 |
Why?
|
| Culture Media | 1 | 1998 | 895 | 0.030 |
Why?
|
| Genes, env | 2 | 1998 | 95 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1998 | 592 | 0.030 |
Why?
|
| Carcinogens | 1 | 1998 | 452 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2019 | 597 | 0.030 |
Why?
|
| HIV-2 | 1 | 1996 | 156 | 0.030 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1996 | 174 | 0.030 |
Why?
|
| Viral Nonstructural Proteins | 1 | 1997 | 227 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 866 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2013 | 2703 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2008 | 3027 | 0.030 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2016 | 149 | 0.030 |
Why?
|
| Xenopus Proteins | 1 | 2018 | 434 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 1178 | 0.030 |
Why?
|
| Tretinoin | 1 | 2018 | 519 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 4433 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 329 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2005 | 1962 | 0.030 |
Why?
|
| Karyotyping | 1 | 2017 | 1171 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 3447 | 0.030 |
Why?
|
| Lactation | 1 | 2017 | 397 | 0.030 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1994 | 56 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2016 | 384 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1998 | 1162 | 0.030 |
Why?
|
| LLC-PK1 Cells | 1 | 1994 | 125 | 0.030 |
Why?
|
| Osteonectin | 1 | 2014 | 33 | 0.030 |
Why?
|
| Lactalbumin | 1 | 2014 | 20 | 0.030 |
Why?
|
| gamma Catenin | 1 | 2014 | 44 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2007 | 3550 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2011 | 1964 | 0.030 |
Why?
|
| Interleukin-18 | 1 | 2016 | 250 | 0.030 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 1994 | 108 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2000 | 1171 | 0.030 |
Why?
|
| Neurons | 2 | 2011 | 9436 | 0.030 |
Why?
|
| Epitopes | 2 | 1999 | 2501 | 0.030 |
Why?
|
| Oxygen | 1 | 2006 | 4226 | 0.030 |
Why?
|
| Dactinomycin | 1 | 1994 | 304 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 1376 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1994 | 343 | 0.030 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1994 | 144 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1994 | 364 | 0.030 |
Why?
|
| Tumor Burden | 2 | 2011 | 1892 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2001 | 2639 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2000 | 3965 | 0.030 |
Why?
|
| Monocytes | 2 | 2022 | 2565 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 1703 | 0.030 |
Why?
|
| HIV Antigens | 1 | 1994 | 325 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 187 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 691 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2000 | 1502 | 0.030 |
Why?
|
| Restriction Mapping | 2 | 1991 | 851 | 0.030 |
Why?
|
| Troponin C | 1 | 2013 | 23 | 0.030 |
Why?
|
| HeLa Cells | 3 | 2010 | 3088 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2013 | 2894 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 1998 | 990 | 0.030 |
Why?
|
| Isoquinolines | 1 | 1994 | 352 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 4 | 1987 | 550 | 0.030 |
Why?
|
| Focal Adhesions | 1 | 2013 | 115 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1088 | 0.030 |
Why?
|
| Cysteine | 1 | 1997 | 891 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 4849 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 1994 | 1519 | 0.030 |
Why?
|
| Glutathione Transferase | 2 | 2007 | 565 | 0.030 |
Why?
|
| Amphibians | 1 | 2012 | 29 | 0.030 |
Why?
|
| Atrazine | 1 | 2012 | 9 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 253 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1999 | 1779 | 0.030 |
Why?
|
| Genes, tat | 1 | 1991 | 15 | 0.030 |
Why?
|
| Sexual Development | 1 | 2012 | 40 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2012 | 195 | 0.020 |
Why?
|
| Evolution, Molecular | 2 | 1997 | 1880 | 0.020 |
Why?
|
| Animals, Wild | 1 | 2012 | 78 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 1997 | 931 | 0.020 |
Why?
|
| Cytoplasm | 2 | 2011 | 1503 | 0.020 |
Why?
|
| Recombinant Proteins | 5 | 2000 | 6520 | 0.020 |
Why?
|
| Neoplasms | 2 | 2012 | 22131 | 0.020 |
Why?
|
| HN Protein | 2 | 1988 | 8 | 0.020 |
Why?
|
| Dioxins | 1 | 2012 | 91 | 0.020 |
Why?
|
| Herbicides | 1 | 2012 | 105 | 0.020 |
Why?
|
| Simian immunodeficiency virus | 1 | 1996 | 810 | 0.020 |
Why?
|
| Cattle | 4 | 1995 | 3841 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1998 | 1946 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 2000 | 3074 | 0.020 |
Why?
|
| SSPE Virus | 1 | 1990 | 4 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2012 | 258 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2015 | 898 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 384 | 0.020 |
Why?
|
| Naphthols | 1 | 2010 | 46 | 0.020 |
Why?
|
| Twins | 1 | 2012 | 340 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2014 | 1848 | 0.020 |
Why?
|
| Culture | 1 | 2014 | 623 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 1226 | 0.020 |
Why?
|
| Nitriles | 1 | 2015 | 971 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2010 | 177 | 0.020 |
Why?
|
| S-Adenosylmethionine | 1 | 2011 | 218 | 0.020 |
Why?
|
| Cadherins | 1 | 2015 | 901 | 0.020 |
Why?
|
| Precipitin Tests | 2 | 2001 | 813 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 2 | 2001 | 901 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 943 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 2011 | 405 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 899 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11735 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 737 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2011 | 214 | 0.020 |
Why?
|
| Actins | 1 | 1997 | 2051 | 0.020 |
Why?
|
| Vaccinia virus | 1 | 1991 | 329 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 489 | 0.020 |
Why?
|
| Sodium | 1 | 1994 | 1588 | 0.020 |
Why?
|
| Autophagy | 1 | 2017 | 1327 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2821 | 0.020 |
Why?
|
| Microfluidics | 1 | 2014 | 651 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 2409 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2016 | 2659 | 0.020 |
Why?
|
| Spleen | 1 | 1994 | 2286 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 1997 | 2382 | 0.020 |
Why?
|
| Government Regulation | 1 | 2013 | 524 | 0.020 |
Why?
|
| Quinazolines | 1 | 2015 | 1371 | 0.020 |
Why?
|
| Proteome | 1 | 2018 | 1857 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 578 | 0.020 |
Why?
|
| Environment | 1 | 2014 | 1123 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1404 | 0.020 |
Why?
|
| Regeneration | 1 | 2017 | 1505 | 0.020 |
Why?
|
| Prognosis | 3 | 2010 | 29601 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 413 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2000 | 4210 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 1186 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 516 | 0.020 |
Why?
|
| Sex Factors | 1 | 2022 | 10549 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2014 | 2358 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1998 | 2674 | 0.020 |
Why?
|
| Viral Core Proteins | 1 | 1988 | 161 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1055 | 0.020 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2007 | 82 | 0.020 |
Why?
|
| Hemagglutinins, Viral | 1 | 1987 | 66 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2008 | 270 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2010 | 458 | 0.020 |
Why?
|
| Sirtuins | 1 | 2010 | 319 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 6188 | 0.020 |
Why?
|
| Embryonic Induction | 1 | 2007 | 151 | 0.020 |
Why?
|
| Endocrinology | 1 | 2013 | 442 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 472 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1994 | 2604 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2011 | 915 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 1756 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 476 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 1998 | 2445 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 283 | 0.020 |
Why?
|
| Jurkat Cells | 2 | 1998 | 740 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2008 | 8311 | 0.020 |
Why?
|
| Antibodies | 1 | 2014 | 2413 | 0.020 |
Why?
|
| Proteins | 2 | 2012 | 6030 | 0.020 |
Why?
|
| Age of Onset | 1 | 2013 | 3303 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2007 | 460 | 0.020 |
Why?
|
| Yeasts | 1 | 2007 | 278 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 1998 | 3037 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2016 | 2565 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3310 | 0.020 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2007 | 150 | 0.020 |
Why?
|
| Response Elements | 1 | 2007 | 309 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 4172 | 0.020 |
Why?
|
| Trypsin | 1 | 2006 | 495 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 3085 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 1132 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2006 | 531 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2008 | 485 | 0.020 |
Why?
|
| Capsid | 1 | 1988 | 433 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1997 | 2533 | 0.020 |
Why?
|
| Mice, Knockout | 3 | 2007 | 14388 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2012 | 1170 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 2108 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1997 | 5109 | 0.020 |
Why?
|
| Pyrazines | 1 | 2011 | 1202 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2010 | 1079 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 2863 | 0.010 |
Why?
|
| DNA, Recombinant | 2 | 1997 | 455 | 0.010 |
Why?
|
| Skin | 1 | 1998 | 4472 | 0.010 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 852 | 0.010 |
Why?
|
| Virulence | 2 | 1998 | 1299 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2015 | 3998 | 0.010 |
Why?
|
| Haplorhini | 2 | 1998 | 525 | 0.010 |
Why?
|
| Rats | 2 | 2014 | 23716 | 0.010 |
Why?
|
| Piperazines | 1 | 1994 | 2521 | 0.010 |
Why?
|
| HIV | 1 | 1991 | 1580 | 0.010 |
Why?
|
| Myocardium | 1 | 1997 | 4725 | 0.010 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1983 | 45 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2008 | 1463 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2008 | 1087 | 0.010 |
Why?
|
| Astrocytes | 1 | 2011 | 1341 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2006 | 1150 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2004 | 223 | 0.010 |
Why?
|
| Progesterone | 1 | 2007 | 742 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4512 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1333 | 0.010 |
Why?
|
| Glucose | 1 | 1994 | 4345 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 59191 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2004 | 207 | 0.010 |
Why?
|
| Pyridones | 1 | 2008 | 808 | 0.010 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 1993 | 119 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8426 | 0.010 |
Why?
|
| Cell Fusion | 2 | 1998 | 294 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2008 | 1392 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1997 | 1692 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2001 | 46 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 2509 | 0.010 |
Why?
|
| Inflammation | 1 | 2022 | 10759 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 3607 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2010 | 4269 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1997 | 4309 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2006 | 9526 | 0.010 |
Why?
|
| Monophenol Monooxygenase | 1 | 2001 | 72 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 2 | 1998 | 1834 | 0.010 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2001 | 105 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2008 | 1626 | 0.010 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2000 | 60 | 0.010 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2000 | 116 | 0.010 |
Why?
|
| HIV Seropositivity | 2 | 1998 | 959 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2017 | 41464 | 0.010 |
Why?
|
| Viscera | 1 | 2000 | 138 | 0.010 |
Why?
|
| Lung | 2 | 2015 | 9999 | 0.010 |
Why?
|
| beta Catenin | 1 | 2005 | 1039 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2001 | 340 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2001 | 473 | 0.010 |
Why?
|
| Endoderm | 1 | 2000 | 160 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 2001 | 335 | 0.010 |
Why?
|
| Solutions | 1 | 2000 | 412 | 0.010 |
Why?
|
| Smad2 Protein | 1 | 2000 | 145 | 0.010 |
Why?
|
| Models, Biological | 2 | 2011 | 9461 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2007 | 2200 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 1336 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 2644 | 0.010 |
Why?
|
| Dimerization | 1 | 2001 | 890 | 0.010 |
Why?
|
| Nevus | 1 | 2001 | 205 | 0.010 |
Why?
|
| Lipids | 1 | 2010 | 3332 | 0.010 |
Why?
|
| Decision Making | 1 | 2013 | 3919 | 0.010 |
Why?
|
| Homeostasis | 1 | 2010 | 3321 | 0.010 |
Why?
|
| Gene Library | 1 | 2001 | 1055 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1998 | 306 | 0.010 |
Why?
|
| Callithrix | 1 | 1998 | 95 | 0.010 |
Why?
|
| Proline | 1 | 2000 | 455 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 927 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2261 | 0.010 |
Why?
|
| Vero Cells | 1 | 1998 | 481 | 0.010 |
Why?
|
| Interferons | 1 | 2001 | 702 | 0.010 |
Why?
|
| Adult | 4 | 2021 | 220995 | 0.010 |
Why?
|
| Stem Cells | 1 | 2010 | 3514 | 0.010 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1996 | 20 | 0.010 |
Why?
|
| 1-Deoxynojirimycin | 1 | 1996 | 18 | 0.010 |
Why?
|
| Microbiological Techniques | 1 | 1998 | 97 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1697 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 2872 | 0.010 |
Why?
|
| Genome, Human | 1 | 2010 | 4421 | 0.010 |
Why?
|
| Swine | 1 | 2007 | 5908 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1997 | 216 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2000 | 790 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1998 | 900 | 0.010 |
Why?
|
| Glycoside Hydrolases | 1 | 1996 | 135 | 0.010 |
Why?
|
| RNA Editing | 1 | 1997 | 151 | 0.010 |
Why?
|
| Integration Host Factors | 1 | 1995 | 12 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2000 | 1989 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1739 | 0.010 |
Why?
|
| Virus Latency | 1 | 1997 | 354 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1997 | 656 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1998 | 813 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 7512 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1987 | 1301 | 0.010 |
Why?
|
| HIV Long Terminal Repeat | 1 | 1993 | 85 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 949 | 0.010 |
Why?
|
| Th1 Cells | 1 | 1998 | 1027 | 0.010 |
Why?
|
| Th2 Cells | 1 | 1998 | 1056 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 1202 | 0.010 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1991 | 76 | 0.010 |
Why?
|
| Diet | 1 | 2010 | 8049 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1998 | 1300 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 23974 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2000 | 5433 | 0.010 |
Why?
|
| Virus Integration | 1 | 1991 | 304 | 0.010 |
Why?
|
| Colon | 1 | 1997 | 1791 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1997 | 3031 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 3705 | 0.000 |
Why?
|
| Rabbits | 1 | 1991 | 4770 | 0.000 |
Why?
|
| Hemagglutination, Viral | 1 | 1983 | 12 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 2 | 1991 | 9171 | 0.000 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1983 | 151 | 0.000 |
Why?
|
| Adsorption | 1 | 1983 | 197 | 0.000 |
Why?
|
| Anti-HIV Agents | 1 | 1998 | 4524 | 0.000 |
Why?
|
| Child | 1 | 1998 | 80089 | 0.000 |
Why?
|
| Adolescent | 1 | 1998 | 88247 | 0.000 |
Why?
|
| Middle Aged | 1 | 1998 | 220603 | 0.000 |
Why?
|